Mapping of genomic mutations and transcriptome expression profiles of non-muscular invasive bladder cancer and its application in individualized precision therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036149

Enrollment

Unknown

Registered

2020-08-21

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Non-muscular invasive bladder cancer; 2. Bladder cancer patients in accordance with Attachment 1; 3. Bladder cancer patients in accordance with Attachment 2.

Exclusion criteria

Exclusion criteria: Advanced bladder cancer

Design outcomes

Primary

Measure	Time frame
Genomic mutation profile and transcriptome expression profile mapping;	—

Countries

China

Contacts

Public ContactCao Dalong

Fudan Universtiy Shanghai Cancer Center

dlcao16@fudan.edu.cn+86 18017317827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026